AbbVie files trade secrets suit against Adcentrx and former employee
20 Dec 2023
ADCPhase 1Patent Infringement
AbbVie accused a former employee and a rival oncology developer of stealing trade secrets about its antibody-drug conjugate programs.
The pharma giant on Friday filed suit in California federal court against Adcentrx and scientist Danny Lee, who left AbbVie in 2021 to join Adcentrx. The complaint alleges that Lee was “in a unique position to know information a competitor would want to know” about AbbVie’s confidential microtubule inhibitor (MTi) ADC program. The company claimed Lee took that information to Adcentrx, which used it to “jump-start” its own ADC program, now in Phase I.
Preview
Source: EndPoints
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
SIGN UP
LOG IN
BECOME A PREMIUM SUBSCRIBER
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.